Every dollar that reaches this platform comes from someone who decided that independent advocacy was worth protecting. There is no pharmaceutical money here. No hospital system grants. No corporate compromise of any kind. Just this.
Cold Ischemia did not begin as a platform. It began as a kitchen table conversation between two people trying to survive a system that had no interest in their survival.
Jeff and Marie Parke spent years navigating end-stage renal disease, home dialysis, and the transplant process — not as observers, not as clinicians, not as policy researchers with comfortable distance from the subject. As the people actually doing it. Three times a week. Every week. While managing equipment failures, insurance denials, provider dismissals, institutional indifference, and the quiet, grinding psychological cost of a role that the healthcare system requires and refuses to acknowledge.
Nobody built tools for them. Nobody wrote the guide they needed. Nobody was pushing for the legislation that would have protected them. The organizations that claimed to speak for patients were funded by the pharmaceutical companies shaping patient outcomes. The advocacy spaces that should have been sanctuaries had become transactional. The care partner — the person holding everything together — was invisible in every room that mattered.
So they built the room themselves.
Jeff & Marie Parke · Founders · Ellenton, Florida
There are hundreds of patient advocacy organizations in the United States. Nearly all of them accept pharmaceutical funding. Nearly all of them have a board member, a program sponsor, or a conference underwriter with a financial stake in the policies they are supposed to evaluate independently.
This is not a conspiracy. It is a structural reality that has quietly shaped what care partners are told, what they are not told, and what questions nobody in the advocacy space ever seems to ask out loud.
"The organizations that claimed to speak for patients were funded by the companies profiting from their illness. We could not fix that from inside it. So we built something outside it entirely."
Cold Ischemia accepts zero pharmaceutical funding. Zero dialysis corporation money. Zero hospital system grants. Zero sponsorships from any entity with a financial interest in the policies we scrutinize. That commitment is written into the foundation's structure — not as a policy that can be quietly reversed when funding gets tight, but as the non-negotiable condition under which this platform exists at all.
That independence costs something. It means this platform runs on membership fees and direct community support. It means we cannot take the easy money. It means every tool, every publication, every federal monitor, every investigative piece we publish answers to one constituency only: care partners.
Your support is what makes that possible.
Independence Pledge — Permanent & Non-Negotiable. The Cold Ischemia Foundation accepts no funding, gifts, grants, sponsorships, or compensation of any kind from pharmaceutical companies, medical device manufacturers, dialysis corporations, transplant centers, hospital systems, or any entity with a financial interest in the policies this foundation exists to challenge. Your support funds this platform. Nothing else does. We answer to one constituency: care partners. No one else. Ever.
Every contribution keeps us independent
One-time or recurring contribution — your choice. No account required.
Want full platform access — all 14 tools, live monitors, and member dashboard? Join as a founding member for $15/month.
Become a Member →